Quarterly ResultAug 7, 2026, 05:28 PM
Creative Medical Q2 Net Loss $(1.51M); Revenue $0; Cash $8.71M
AI Summary
Creative Medical Technology Holdings, Inc. reported a net loss of $(1.51) million for the three months ended June 30, 2026, with no revenue generated during the period. For the six months ended June 30, 2026, the net loss was $(2.92) million. Despite ongoing losses, the company's cash balance increased to $8.71 million, primarily due to $4.48 million in proceeds from warrant exercises.
Key Highlights
- Net loss for the three months ended June 30, 2026, was $(1,511,976), compared to $(1,233,303) in the prior year period.
- The company reported no revenue for the three and six months ended June 30, 2026.
- Cash balance increased to $8,714,115 as of June 30, 2026, from $7,208,126 at December 31, 2025.
- Total assets increased to $9,377,653 as of June 30, 2026, from $7,809,525 at December 31, 2025.
- Net cash provided by financing activities was $4,476,544 for the six months ended June 30, 2026, primarily from warrant exercises.
- Research and development expenses for the six months ended June 30, 2026, were $1,000,858.
- Net loss per share for the three months ended June 30, 2026, was $(0.41), an improvement from $(0.48) in the prior year.
Price Impact
More from CELZ